Thyrocare Technologies Ltd.

View in App
659.95 +15.60 ▲2.4%

24 April 2024, 04:11:38 PM
Volume: 106,905

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Industry Icon Hospital & Healthcare Services Compare with Industry peers
Website http://www.thyrocare.com
Market Cap 3,493.02 Cr.
Enterprise Value(EV) 3,492.17 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 12.39 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 53.26 Trailing Twelve Months Ending 2023-12
Industry PE 67.43 Trailing Twelve Months Ending 2023-12
Book Value / Share 94.59 Trailing Twelve Months Ending 2023-12
Price to Book Value 6.97 Calculated using Price: 659.65
Dividend Yield 2.73 Period Ending 2023-03
No. of Shares Subscribed 5.30 Cr. 52,952,676 Shares
FaceValue 10
About Thyrocare Technologies Ltd.
Thyrocare Technologies is an India-based healthcare service provider. The Company operates with a centralized processing laboratory (CPL) in Mumbai, India for esoteric tests, and regional processing laboratory in metro cities of India and other parts of Asia. The Company offers technologies, including Chemiluminescence Immunoassay (CLIA), Enzyme Linked Immunosorbent Assay (ELISA), High Performance Liquid Chromatography (HPLC), Capillary Electrophoresis (CE), Ion Selective Electrode (ISE), Fluorescence Flow Cytometry, Nephelometry, Photometry, Liquid Chromatography Mass Spectrometry (LC-MS), Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) and Cytogenetics. The Company offers cancer diagnosis and water testing through its brands Nueclear and Whaters, respectively.

Thyrocare Technologies Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Thyrocare Technologies Ltd. Performance

View details >>
1 Day
+2.42%
1 Week
+6.08%
1 Month
+8.04%
3 Month
+5.64%
6 Month
+22.92%
1 Year
+44.00%
2 Year
-20.85%
5 Year
+33.61%
10 Year

Thyrocare Technologies Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 15.98 16.22 11.19 22.12 19.53 22.26 28.75 37.18 12.23
Return on Capital Employed (%) 24.57 25.66 21.04 33.89 31.48 35.27 38.51 48.42 17.61
Return on Assets (%) 13.41 14.09 10.19 20.55 18.05 18.84 22.43 25.38 7.65

Thyrocare Technologies Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 276 366 408 443 435 367 427 527 534 486
Non Curr. Liab. 9 10 9 10 14 21 18 106 149 23
Curr. Liab. 7 31 18 20 21 82 95 215 151 69
Minority Int. 36 1 1
Equity & Liab. 328 407 434 474 470 469 540 848 835 579
Non Curr. Assets 218 273 285 332 334 317 300 427 488 370
Curr. Assets 111 134 150 142 117 121 200 421 347 209
Misc. Exp. not W/O
Total Assets 328 407 434 474 470 469 540 848 835 579

Thyrocare Technologies Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 183 241 304 356 403 434 495 589 527 554
Other Income 8 7 12 23 10 7 12 29 8 10
Total Income 191 248 317 379 413 441 507 618 535 563
Total Expenditure -110 -147 -189 -212 -249 -261 -323 -353 -404 -425
PBIDT 81 101 128 168 164 180 184 265 131 138
Interest 0 -1 0 0 -1 -2 -1 -3 -5 -4
Depreciation -13 -18 -18 -20 -26 -32 -30 -34 -39 -45
Taxation -24 -30 -39 -52 -53 -52 -39 -52 -24 -26
Exceptional Items -27 -2 -7
PAT 44 52 43 93 85 88 113 176 64 64
Minority Interest 1 1
Share Associate 1
Other Related Items 0 0 0 0 -1 0 2
Consolidated Net Profit 45 52 43 93 85 89 112 176 66 66
Adjusted EPS 9 10 8 17 16 17 21 33 12 12

Thyrocare Technologies Ltd. Cash Flow

View details >>
Particulars 9 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 34 68 90 107 100 168 115 113 129
Cash Fr. Inv. -18 -18 -42 -43 -12 1 -49 -24 -39
Cash Fr. Finan. -23 -45 -49 -64 -94 -165 -62 -89 -86
Net Change -6 5 0 0 -5 4 4 0 4
Cash & Cash Eqvt 5 10 10 10 5 9 13 14 18

Thyrocare Technologies Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 71.18 71.18 71.14 71.14 71.14 71.14 71.14 71.11 71.11
Public 28.82 28.82 28.86 28.86 28.86 28.86 28.86 28.89 28.89
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
No. of Shareholders (in Lacs)

Thyrocare Technologies Ltd. Announcements

View details >>
Wed, 17 Apr 2024
Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
THYROCARE TECHNOLOGIES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
Tue, 16 Apr 2024
Updates
Thyrocare Technologies Limited has informed the Exchange regarding 'Resignation of Mr Ankit Brijpuriya as Deputy Company Secretary and Deputy Compliance Officer of the company w.e.f. April 26, 2024.'.
Sat, 06 Apr 2024
Updates
Thyrocare Technologies Limited has informed the Exchange regarding 'Revised Rectification order passed by the Income Tax Department Mumbai'.

Thyrocare Technologies Ltd. Technical Scans

View details >>
Wed, 24 Apr 2024
Closing Above Previous High Closing Above Previous High
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 1 Month High Increase in 1 Month
High Increase in 6 Months High Increase in 6 Months
High Increase in 1 Year High Increase in 1 Year

Thyrocare Technologies Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 356,625.15 1,485.75 +0.1%
Cipla Ltd. 112,938.41 1,398.20 +3.8%
Divi's Laboratories Ltd. 101,314.76 3,813.80 +1.2%
Dr. Reddy's Laboratories Ltd. 99,276.89 5,950.80 0.0%
Mankind Pharma Ltd. 96,143.23 2,398.30 +0.2%
Zydus Lifesciences Ltd. 93,921.88 933.50 -2.7%
Torrent Pharmaceuticals Ltd. 90,872.60 2,686.45 +1.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.04 1,485.75 +0.1%
Cipla Ltd. Consolidated 2023-12 30.46 1,398.20 +3.8%
Divi's Laboratories Ltd. Consolidated 2023-12 73.26 3,813.80 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 18.99 5,950.80 0.0%
Mankind Pharma Ltd. Consolidated 2023-12 55.67 2,398.30 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.58 933.50 -2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.83 2,686.45 +1.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.72 1,485.75 +0.1%
Cipla Ltd. Consolidated 2023-12 4.36 1,398.20 +3.8%
Divi's Laboratories Ltd. Consolidated 2023-12 7.77 3,813.80 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.69 5,950.80 0.0%
Mankind Pharma Ltd. Consolidated 2023-12 10.82 2,398.30 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.98 933.50 -2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.71 2,686.45 +1.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,485.75 +0.1%
Cipla Ltd. Consolidated 2023-03 0.02 1,398.20 +3.8%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,813.80 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,950.80 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,398.30 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 933.50 -2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,686.45 +1.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,485.75 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,398.20 +3.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,813.80 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,950.80 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.30 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 933.50 -2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,686.45 +1.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,485.75 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,398.20 +3.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,813.80 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,950.80 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.30 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 933.50 -2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,686.45 +1.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,485.75 +0.1%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,398.20 +3.8%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,813.80 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,950.80 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,398.30 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 933.50 -2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,686.45 +1.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,485.75 +0.1%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,398.20 +3.8%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,813.80 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,950.80 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,398.30 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 933.50 -2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,686.45 +1.9%

Thyrocare Technologies Ltd. FAQ's

What is Thyrocare Tech. share price?
Can I buy Thyrocare Tech. shares now?
What is the Dividend Yield of Thyrocare Tech.?
What is the Market Cap of Thyrocare Tech.?
What are the key metrics to analyse Thyrocare Tech.?
What is the 52 Week High and Low of Thyrocare Tech.?
What is the trend of Thyrocare Tech. share price?